The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) and is used in the treatment of seizures.
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
The products will be manufactured at the company's facility in Bengaluru
The products will be manufactured at the company's facility in Bengaluru
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
The approval bolsters the company's Mycophenolate Mofetil portfolio
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Subscribe To Our Newsletter & Stay Updated
